RE:ACB should raise the offer to $28 to $30 and be done with itWouldn't pay a cent more then 24. Every day new companys are gaining traction. TGOD etc.. that don't have a cancer management team. Cmed is a good pick up but ACB is not stupid. They will only do the deal the way they want it. 5 months ago the shareholders were crying for canopy to buy them for 15 bucks. Management said no. Now a better company wants them and all of a sudden there sh;t dosent stink.? 24 or let em sink. Wasting time..